Other analysts have also recently issued reports about the stock. HC Wainwright reiterated a buy rating and issued a $6.50 target price on shares of Edap Tms in a research note on Friday, November 15th. Zacks Investment Research upgraded shares of Edap Tms from a hold rating to a buy rating and set a $5.00 price target for the company in a research report on Friday, January 3rd.
Shares of NASDAQ EDAP traded down $0.03 during mid-day trading on Wednesday, hitting $4.16. The company had a trading volume of 1,465 shares, compared to its average volume of 95,533. Edap Tms has a 1 year low of $2.40 and a 1 year high of $5.42. The company has a market capitalization of $118.90 million, a price-to-earnings ratio of 208.50 and a beta of 1.62. The stock’s 50-day moving average price is $4.56 and its 200-day moving average price is $4.00.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Russell Investments Group Ltd. increased its stake in Edap Tms by 168.4% in the third quarter. Russell Investments Group Ltd. now owns 7,332 shares of the medical equipment provider’s stock valued at $33,000 after acquiring an additional 4,600 shares during the last quarter. Morgan Stanley increased its stake in Edap Tms by 222.7% in the 2nd quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock worth $722,000 after purchasing an additional 184,539 shares during the period. Commonwealth Equity Services LLC lifted its position in Edap Tms by 25.0% in the third quarter. Commonwealth Equity Services LLC now owns 32,540 shares of the medical equipment provider’s stock valued at $146,000 after purchasing an additional 6,500 shares during the last quarter. JPMorgan Chase & Co. bought a new stake in Edap Tms in the second quarter valued at approximately $282,000. Finally, Susquehanna International Group LLP boosted its stake in shares of Edap Tms by 762.9% during the second quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock valued at $556,000 after purchasing an additional 181,401 shares during the period. 12.04% of the stock is owned by institutional investors.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Further Reading: What is the outlook for the FAANG stocks?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.